Skip to search formSkip to main contentSkip to account menu

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

Known as: 7-hydroxy-delta-6-tetrahydrocannabinoldimethylheptyl, DEXANABINOL, 5'(1,1-dimethylheptyl)-7-hydroxyhexahydrocannabinol 
A synthetic, terpene-based cannabinoid derivative devoid of cannabinoid receptors 1 and 2 agonist activity and with potential neuroprotective… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

HU 211
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Effects of endocannabinoid system, synthetic and nonsynthetic cannabinoid drugs on traumatic brain injury outcome: a narrative review
Traumatic brain injury (TBI) is the leading cause of morbidity and mortality worldwide. The initial injury is followed by a… 
2015
2015
ATNT-13A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF DEXANABINOL IN PATIENTS WITH BRAIN CANCER
BACKGROUND: Dexanabinol is a synthetic analogue of tetrahydrocannabinol previously developed as a neuroprotector and subsequently… 
2008
2008
Dexanabinol prevents development of vasospasm in the rat femoral artery model
We postulated that a multi-potential agent such as dexanabinol may prevent the development of vasospasm after subarachnoid… 
2005
2005
1H and 13C assignments of three new drimenes from Iresine diffusa Humb. & Bonpl. ex Willd.
The structure elucidation and 1H and 13C assignments of iresin (1) and three new drimenes, 3β,14‐dihydroxy‐Δ7, 8‐drimen‐11,12… 
2003
2003
A Viable Neuroprotection Strategy Following Soman-induced Status Epilepticus
Abstract : The present study examined the neuroprotective effectiveness of dantrolene in the prevention of soman-induced SRBD… 
Review
2003
Review
2003
[New therapies for intracranial hypertension].
OBJECTIVE The main concepts involved in the therapeutic management of intracranial hypertension are revisited, including… 
1999
1999
Dimethylheptyl-THC-11-oic Acid
THC-11-oic acid, a non-psychoactive derivative of Δ9-THC, inhibits cyclooxygenase and platelet-activating factors, which are the… 
1998
1998
Safety and Outcome in a Phase II Clinical Trial of Dexanabinol in Severe Head Trauma
1997
1997
Dimerization of Dexanabinol by Hydrogen Bonding Accounts for Its Hydrophobic Character
Dexanabinol, a dihydroxylated synthetic cannabinoid, is a member of . the nonpsychotropic q 3S, 4S enantiomeric series… 
1996
1996
Derivatives of Dexanabinol. II. Salts of Amino Acid Esters Containing Tertiary and Quaternary Heterocyclic Nitrogen with Increased Water-Solubility
AbstractPurpose. Amino acid esters containing tertiary or quaternary nitrogen heterocycles were synthesized for dexanabinol (1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)